Skip to content

HealthEquity

US · HQY #1726 by market cap Listed 1970
94.75 -2.63 -2.70%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 17 in the most recent period (2026/Q3).
  • Total institutional ownership rose 6.9 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
117.08% +6.90pp
Institutions
621 +17
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund95.44%
Hedge Fund8.78%
Public Company6.79%
Private Company2.25%
Individual/Insider2.07%
Government Pension Fund1.93%
Sovereign Wealth Fund0.69%
Insurance Company0.53%
Family Office/Trust0.47%

Top holders as of 2026-09-30

BlackRock 13.66% · 11.30M sh
Wasatch Advisors LP 8.48% · 7.01M sh
Vanguard Portfolio Management, LLC 4.78% · 3.95M sh
Morgan Stanley Investment Management Inc. 4.60% · 3.81M sh
Morgan Stanley 4.60% · 3.81M sh
Vanguard Capital Management, LLC 4.32% · 3.58M sh
State Street Global Advisors 3.92% · 3.24M sh
Eaton Vance Management 2.94% · 2.43M sh
Dimensional Fund Advisors 2.26% · 1.87M sh
Geode Capital Management, LLC 2.81% · 2.33M sh
AQR Capital Management 2.41% · 1.99M sh
William Blair Investment Management, LLC 2.20% · 1.82M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 18 buys · 29 sells

NameRoleStake
Stephen Neeleman Founder & Vice Chairman 1.04%
Jon Kessler Former Director & Special Advisor 0.40%
Robert Selander Independent Non-Executive Chairperson 0.11%
Elimelech Rosner Former Chief Technology Officer 0.10%
Adrian Dillon Independent Director 0.07%
Delano Ladd General Counsel 0.07%
Sunil Rajasekar Executive VP and Chief Product & Strategy Officer 0.06%
Evelyn Dilsaver Independent Director 0.06%
James Lucania Chief Financial Officer 0.05%
Scott Cutler Chief Executive Officer 0.03%
Stuart Parker Independent Director 0.03%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-14 Sunil Rajasekar Executive VP and Chief Product & Strategy Officer Open Market Acquisition +131 $90.33–95.06
2026-10-05 James Lucania Chief Financial Officer Sale to Issuer -2,822 $91.16
2026-10-05 Stephen Neeleman Founder & Vice Chairman Sale to Issuer -1,095 $91.16
2026-10-05 Scott Cutler Chief Executive Officer Sale to Issuer -1,230 $91.16
2026-10-05 Delano Ladd General Counsel Sale to Issuer -1,080 $91.16
2026-10-05 Michael Fiore Former Executive Vice President Sale to Issuer -2,032 $91.16
2026-10-05 Michael Gathright -- Sale to Issuer -662 $91.16
2026-09-23 Noemie Heuland Director Initial Statement of Beneficial 0 --
2026-09-16 Stephen Neeleman Founder & Vice Chairman Other Disposition -1,500 --
2026-08-24 Adrian Dillon Independent Director Derivative Exercise and Sale -7,632 $32.50–105.26
2026-08-23 Sunil Rajasekar Executive VP and Chief Product & Strategy Officer Open Market Disposition -131 $82.81–105.60
2026-07-09 Michael Fiore Former Executive Vice President Open Market Disposition -2,354 $95.00
2026-07-08 Michael Gathright -- Sale to Issuer -2,270 $93.07
2026-07-07 James Lucania Chief Financial Officer Sale to Issuer -2,839 $95.08
2026-07-07 Stephen Neeleman Founder & Vice Chairman Sale to Issuer -1,103 $95.08
2026-07-07 Scott Cutler Chief Executive Officer Sale to Issuer -1,238 $95.08
2026-07-07 Delano Ladd General Counsel Sale to Issuer -1,087 $95.08
2026-07-07 Michael Fiore Former Executive Vice President Sale to Issuer -2,045 $95.08
2026-07-01 Michael Fiore Former Executive Vice President Automatic Disposition -2,470 $95.00
2026-06-24 Adrian Dillon Independent Director Other Acquisition +2,877 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

HealthEquity discussion 0 comments

Add a comment